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Abstract: Implementation of efficacious dietary interventions to regulate energy balance requires
understanding of the determinants of individual response. To date, information regarding individual
variability in response to elevated meal protein content is lacking. This study investigates whether
sex and/or oral contraceptive pill (OCP) use play a role in the response to elevated meal protein in
21 healthy young adults (seven men, seven women not taking OCP, and seven women who were
OCP users). Participants consumed each of three standardized isocaloric (590 kcal) meals of differing
protein content (11, 23, 31% kcal protein). Resting energy expenditure (EE), respiratory quotient
(RQ), hunger and satiety were measured at baseline (fasting) and during 180 min postprandial.
Whilst significant dose–response increases in EE were observed in men, meal protein-induced
EE in women without OCP reached a maximum at <23% protein. Women taking OCP reported
lower postprandial fullness than women without OCP, despite similar body size, but also, most
notably, no significant difference in EE response between any of the meals. Whilst the mechanisms
underpinning this thermogenic inflexibility in response across a wide-range (three-fold) of protein
meal content require further investigation, this highlights the need for careful consideration of factors
that may influence an individual’s metabolic response to dietary interventions aimed at optimising
postprandial thermogenesis for body weight regulation.
Keywords: dietary protein; energy metabolism; sex difference; oral contraceptive pill; thermogenesis;
energy balance
1. Introduction
In the search for dietary strategies to enhance thermogenesis for the management of obesity and
obesity relapse (successful long-term weight maintenance), dietary protein has been a focus of much
research. However, whilst increasing protein consumption has been shown to be somewhat effective
in modulating energy balance at a macro-level [1,2], there appears to be a high degree of variability
in individual responses to such interventions [3,4]. Indeed, in a recent study, we demonstrated no
greater thermic effect of a high protein (24% total energy from protein) versus normal protein (11%)
meal in women taking the combined, monophasic oral contraceptive pill (OCP) [5]. Although the
mechanisms underpinning this differential response are not yet known, it should be noted that high
protein diets administered in the context of weight management often include meals comprising about
30% of energy intake as protein, that is, higher than the 24% protein meal used in our above-mentioned
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study [5]. Combined with concerns about the long-term consequences of “too high” protein diets on
kidney function and risks for cardiovascular diseases [6], there is therefore a need to determine whether
or not the effect of contraceptive pill use on metabolic responsiveness to dietary protein persists at
this higher level of meal protein content (i.e., 30% by energy), whether any sex-differences in response
become apparent across a wider content range, and to establish the range of what could constitute an
acceptable “high-protein” diet for weight management. Crucially, and perhaps surprisingly, to date
there has been no comprehensive, laboratory-controlled study investigating the acute dose–response
relationship between meal protein content and postprandial energy expenditure (EE) under isocaloric
conditions. As interest into the effects of OCP on the thermogenic and satiety responses to dietary
protein levels is novel, it is important to first describe its impact in healthy young lean subjects—which
furthermore may have implications for the development and prevention of obesity.
Therefore the aim of the present study was to investigate the dose–response relationship between
meal protein content, energy expenditure (EE), respiratory quotient (RQ; an index of substrate
utilisation) and satiety in healthy young adults by investigating these metabolic responses to the
ingestion of three standardized isocaloric diets of differing protein content (11, 23, and 31% kcal
protein), particularly taking into account the role of sex and OCP use. We hypothesised that the
thermogenic and satiety responses to the meal would increase in a stepwise fashion in response to
increasing meal protein content in men and in women without OCP, but not in women using OCP.
2. Materials and Methods
2.1. Subjects
14 healthy, non-obese young women (7 not taking and 7 taking the combined, monophasic
OCP), and 7 healthy, young men were recruited for this study. The number of required subjects was
determined by power analysis using web-based software (http://clincalc.com/stats/samplesize.aspx)
with a type I error (α) of 0.05 and a desired power (1 − β) of 0.90. Based on our previous work [5],
to detect a difference in the area-under-curve (AUC) (normal–high protein) for EE between –OCP
and +OCP of 0.05 kcal/min based on a SD of 0.04 kcal/min, a sample size of 7 subjects per group
was required.
Exclusion criteria were as follows: regular smokers, claustrophobic, pregnant or breastfeeding
women, subjects with acute infections, chronic inflammatory disease, a history of metabolic disease
(e.g., diabetes), cardiovascular disease, neurological or gastro-intestinal disease, eating disorders or
food allergies, irregular menstruation, or taking medication other than the OCP which could interfere
with metabolic rate. All women in the OCP group had been taking a pill containing 26 ± 3µg (mode:
20 µg) of ethinyl estradiol for at least 3 months, as per the manufacturer’s instructions.
This study complied with the Declaration of Helsinki and was approved by the state ethical
review board; all participants gave written consent. This study was registered within the ISRCTN
registry prior to recruitment (ISRCTN57611296).
2.2. Experimental Design
After an initial screening visit to complete the consent process and a diet/lifestyle questionnaire,
participants attended the laboratory for three experimental sessions, with at least a 2 day interval
between sessions. Subjects were asked to avoid intense physical activity and to abstain from alcohol
and caffeine-containing foods and beverages for 24 h before each test. On the day of testing, participants
arrived at the laboratory at 8:00 am following a 12 h overnight fast. Testing was conducted in the follicular
phase of the menstrual cycle in women not taking OCP, and the week following withdrawal bleeding
in women taking the OCP. Body composition was determined using multifrequency bioimpedance
analysis (InBody 720, Biospace Co., Ltd., Seoul, Korea). Measurements of oxygen consumption (VO2)
and carbon dioxide elimination (VCO2) were carried out using an open-circuit indirect calorimeter
equipped with a ventilated canopy (hood) system (Quark CPET, COSMED, Rome, Italy). As previously
Nutrients 2019, 11, 1599 3 of 11
described [5], participants were seated comfortably in a car seat adapted for calorimetric monitoring,
with metabolic measurements conducted for at least 30–40 min, after 15 min of rest; for each subject the
mean of last 30 min was taken as the baseline (fasted) value. The ventilated hood was then removed
while the subject ingested one of the three test meals described below, consumed within 10 min.
The ventilated hood was replaced, and calorimetric monitoring was continued for a further 180 min.
While not capturing the entire thermic response, this duration of measurement minimises discomfort
of the subjects under canopy, and has been shown to highly correlate (r > 0.95) with 6 h meal-induced
thermogenesis for a test meal of this caloric content [7]. Participants were permitted to watch a calm
movie or a documentary during the metabolic measurements but were not permitted to consume any
additional foods or beverages (including water).
2.3. Test Meals
During each visit, participants consumed one of three ~590 kcal isocaloric test meals of varying
protein content (11, 23, or 31% total energy from protein). Meals consisted of a simple breakfast
meal base (oats, ground almonds, yoghurt, double cream) to which a protein powder supplement
(containing 4:1 ratio of casein to whey protein) was added to increase the protein content as necessary,
while maintaining the ratio of fat to carbohydrate constant at 0.71, as detailed in Table 1. Whilst the
ingredients used in these test meals differed from our previous study [5], the ratio of non-protein
macronutrients and total energy content of the meals used here were matched to our previous study [5]
to facilitate comparison of results. The order of the test meals was randomized using a simple,
single-block randomization plan (http://www.randomization.com), and participants were blinded to
the meal content.
Table 1. Test meal composition (calculated) as a load for assessing postprandial thermogenesis.
Protein
(% Total
Energy)
Quantity (g) Energy (kcal)
Ratio
Fat: CHORolled
Oats
Ground
Almonds Yoghurt
1 Double
Cream 2
Protein
Supplement 3 Protein Fat CHO
4
11% 80 6 180 20 0 73 216 306 0.71
23% 62 12 190 13 8 137 189 267 0.71
31% 50 16 200 4 20 182 171 243 0.71
1 Yoghurt (11%: M-Classic Blueberry, Migros, Switzerland; 23% and 31%: YoQua Blueberry, Emmi, Switzerland);
2 Double Cream (Double crème de la Gruyère, Migros, Switzerland); 3 Protein Supplement (Protifar, Nutricia,
Schiphol, the Netherlands); 4 CHO, carbohydrate.
2.4. Visual Analog Scales
In order to assess postprandial satiety, measures of hunger and fullness were obtained by
visual analog scale (VAS) rating at baseline and 60, 120, and 180 min postprandial, according to the
methodology of Stubbs et al. [8,9]. Specifically, participants were asked to rate their fullness (i.e., “how
full are you at this moment”; anchors: “not at all full” to “extremely full”), desire to eat (i.e., “how
strong is your desire to eat at this moment?”; anchors: “not at all strong” to “extremely strong”), and
prospective food consumption (i.e., “how much food do you think you could eat at this moment?”;
anchors: “none” to “a large amount”).
2.5. Data Analyses
EE was calculated according to the Weir equation [10], with urinary nitrogen excretion assumed to
be at a fixed average value of 13 g/24 h for each subject, reflecting the rate of urinary nitrogen excretion
in the post-absorptive state [11]. Note that even a potential error of 10% in the N excretion would
not significantly affect resting EE for two reasons: (1) The protein correction has very small power in
the calorimetric equation, as compared to carbohydrate (CHO) oxidation and fat oxidation; and (2)
the respiratory quotient (RQ) of protein oxidation (0.83) is in the middle band of the physiological
RQ extreme span (0.7 for fat to 1.0 for CHO). RQ was derived from the ratio between VO2 and VCO2
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(i.e., VCO2/VO2). The min-by-min EE, RQ and HR data yielded were processed as means of 30 min
during the baseline and post-prandial period. All data are presented as mean ± SEM unless otherwise
stated. Statistical analyses by one-way analysis of variance (ANOVA) or repeated-measures ANOVA
followed by Dunnett’s multiple comparison tests (versus baseline) or Bonferroni post-tests (between
groups) were performed using the computer software STATISTIX version 8.0 (Analytical Software, St
Paul, MN, USA).
3. Results
3.1. Participant Characteristics
The age, anthropometry and body composition data for the three subject groups are provided
in Table 2. There were no significant differences in any of these parameters between the women
taking the OCP (+OCP) and those not taking the OCP (-OCP). To determine the effect of sex on these
characteristics, we compared men to all women (n = 14), and to the –OCP group alone, and found no
significant differences in terms of age. However, the men were, on average, taller and heavier (both p
< 0.001), with greater BMI (p = 0.01) and fat-free mass (p < 0.001), and a lower %Fat (p < 0.005) than
the women.
Table 2. Participant characteristics (mean ± SEM).
Men Women p-Value
-OCP 3 +OCP 3 Men v -OCP -OCP v +OCP 3
n 7 7 7
Age (year) 23.0 ± 0.6 24.4 ± 0.9 22.6 ± 0.6 0.6 0.12
Weight (kg) 76.1 ± 2.3 61.5 ± 2.3 59.2 ± 2.0 < 0.001 0.48
Height (cm) 177 ± 1.5 164 ± 2.3 168 ± 1.6 < 0.001 0.21
BMI 1 (kg/m2) 24.3 ± 0.6 22.8 ± 0.7 21.0 ± 0.6 0.01 0.08
FFM 2 (kg) 64.0 ± 2.0 44.5 ± 1.3 44.5 ± 1.6 < 0.001 0.97
%Fat 15.6 ± 2.9 26.8 ± 2.1 24.9 ± 1.9 < 0.005 0.52
1 BMI: Body mass index; 2 FFM: Fat-free mass; 3 OCP: Oral contraceptive pill.
3.2. Baseline (Fasted) EE
Whilst baseline (fasted) EE was significantly higher in men than women (p < 0.0001; Table 3), this
difference was no longer observed when adjusted for fat-free mass (p = 0.51). Similarly, there was no
effect of OCP use (p = 0.74) on baseline EE, nor any difference in baseline EE across experimental days.
The mean intra-individual coefficient of variation (CV) values for baseline (fasted) EE measured across
the three experimental days were less than 6% in all three groups, in line with the intra-individual CV
often reported for basal metabolic rate (BMR) [12].
Table 3. Baseline (fasted) parameters (3 day mean ± SEM).
Men Women p-Value
-OCP 3 +OCP 3 Men v -OCP -OCP v +OCP3
Indirect Calorimetry
EE (kcal/min) 1 1.26 ± 0.05 0.90 ± 0.03 0.89 ± 0.03 < 0.001 0.74
RQ 2 0.809 ± 0.01 0.823 ± 0.02 0.824 ± 0.02 0.42 0.98
Visual Analog Scales
Fullness (mm) 4 23 ± 6 12 ± 3 11 ± 4 0.04 0.87
Desire to eat (mm) 4 64 ± 5 62 ± 8 69 ± 6 0.83 0.53
Prospective food
consumption (mm) 4 59 ± 8 64 ± 7 64 ± 6 0.52 0.95
1 EE: Energy Expenditure; 2 RQ: Respiratory quotient; 3 OCP: Oral contraceptive pill; 4 range of visual analog scale
= 0–100 mm.
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3.3. Postprandial EE
Figure 1 shows changes in resting EE (∆EE) following ingestion of an isocaloric meal containing
either 11, 23, or 31% of total energy as protein in a repeated measure design. A dose–response was
observed in men, with significant stepwise increases in EE with increasing protein dose (Figure 1A,B;
p < 0.05). In women not taking OCP (women -OCP group), the 23% protein meal significantly increased
EE above the level observed following the 11% protein meal (Figure 1C and 1D; p < 0.001); however,
no significant increase in EE between the 23% and the 31% protein meal was observed (p = 0.8).
Interestingly, no effect of meal protein content was seen in women taking OCP (women +OCP group),
with no significant difference in response between any of the test meals (Figure 1E,F; p = 0.9).
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3.4. Respiratory Quotient (RQ)
There was no effect of day, sex, or oral contraceptive use on baseline RQ (Table 3), nor was there
any significant difference in RQ response between any of the test meals (see supplementary Figure S1).
3.5. Visual Analog Scale (VAS) Ratings
Within each subject group, no differences in VAS ratings were observed at baseline between test
days. On average men reported slightly, but significantly, less fullness at baseline than women (p = 0.04;
Table 3), although no such differences were found in desire to eat or prospective food consumption.
As expected, changes in all three VAS ratings (increase in fullness and decreases in desire to eat and
prospective food consumption) were observed after each meal. However, there were no significant
between-meal differences in these ratings at any time-point, nor when integrated over the three hour
postprandial period.
Comparison across subject groups and across meals at baseline (fasting state) indicates an effect of
sex for VAS ratings of fullness only (p < 0.05), with men scoring higher levels of fullness at baseline than
women. However, analysis of the changes in VAS ratings during the postprandial period (Figure 2)
indicate (i) a significant effect of sex for all three VAS ratings, with women showing a greater effect than
men, and also (ii) women not taking the pill showing a significantly greater VAS ratings of postprandial
fullness than either men or women taking pill (p < 0.05).
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4. Discussion
In the present study we investigated the dose–response relationship between meal protein content
and resting EE, respiratory quotient, and satiety in healthy young men and women, in response to
three different levels of protein intake (11, 23, and 31% kcal protein), in line with the range of high
protein diets often investigated for body weight regulation and maintenance. As no previous effects
of the menstrual cycle on the thermogenic responses to protein meals were observed [5], this study
was conducted only in the follicular phase in the female subjects. We hypothesised that resting EE
and satiety would increase in a stepwise fashion in response to increasing dietary protein intake.
Indeed, our results agreed with this hypothesis in men, with significant dose–response increases in EE
with increasing protein dose observed in men. However, in women without OCP, the 23% protein
meal increased EE above the level observed following the 11% protein meal (p < 0.001), but a further
increase in EE between the 23% and the 31% protein meal was not observed. Strikingly, in line with
our previous study [5], no effect of meal protein content was seen in women taking the OCP, with no
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significant difference in response between any of the test meals, representing a three-fold range of meal
protein content. The mechanisms underlying this single-level response (i.e., thermogenic inflexibility)
across such a wide range of protein intakes remains to be studied. However, coupled with the lack of
differential response to the two higher doses in women not taking the OCP, it would appear that a
theoretical metabolic ceiling may be reached, particularly in women taking the OCP. As a result, it could
be hypothesised that the protein-induced thermogenic response is operating to its maximum level
above a certain threshold of exogenous protein intake. The potential mechanisms involved may be
related to the control of protein flux and protein turnover or its two components; namely, whole-body
protein synthesis (expensive in ATP need), and whole-body protein breakdown. Both components
are being increased acutely following a high protein meal, and also following prolonged feeding
with a high protein diet [13]. Another metabolic process, costly in terms of ATP need, is that of liver
gluconeogenesis—de novo synthesis of glucose from amino acid precursors released through increased
protein breakdown. However, this process is markedly stimulated if the amount of exogenous CHO is
low [14]. Further exploration of our hypothesis of a putative “physiological ceiling” would require
more in-depth research by non-invasive techniques (such as the use of stable isotopes) to investigate
protein metabolism and turnover. In particular, to investigate the dynamic regulation of exogenous
protein utilisation in terms of changes in whole-body protein synthesis in relation to changes in
whole-body protein breakdown. Although the literature is very scarce on this issue, we suspect that
the hormonal changes induced by OCP are also susceptible to influence amino-acid metabolism [14].
In Western countries, the majority of women habitually consume a diet containing approximately
15% total energy as protein [15], and as such intervention strategies aimed at stimulating diet-induced
thermogenesis through a high-protein diet could be challenged, as most of the benefit in terms of
energy expenditure is already operating. Similarly, it is currently unclear if the homogenous level
of response observed in women taking the OCP represents a caloric response, insensitive to meal
protein content, or if there is a lower threshold of meal protein content above which the “all-or-nothing”
response is stimulated. These questions warrant further investigation, particularly in light of (i) rates
of female obesity exceeding those of men across all regions of the globe [16]; (ii) sex disparities in the
effectiveness of current intervention strategies [17]; and (iii) the commonplace usage of the exogenous
female sex hormones (e.g., for contraception or replacement therapy) [18–21].
In order to investigate the effect of increasing protein meal content on appetite and satiety, we
also utilized visual analogue scale (VAS) ratings of fullness, desire to eat, and prospective of food
consumption. These data reveal (i) a significant effect of sex for all three VAS ratings, with women
showing a greater effect than men, and also (ii) women without OCP showing a significantly greater
mean VAS rating for fullness than men or women taking the OCP. Despite several studies showing a
greater satiety effect after the consumption of a high protein meal than after a normal protein meal [22],
the question remains as to why the satiety ratings did not correspond to the energy expenditure data.
One possible explanation, particularly in terms of the difference noted between men and women,
was that the meal size (volume and caloric content) was fixed, and not adjusted according to the body
size or composition of the subject. As such the calorie load was greater in the women than the men on
a body size basis. Another possible reason is that the VAS scale is a subjective approach and the subject
may consciously or subconsciously choose to override their appetite cues when filling in the scale.
The physiologic responses are not always in line with perceived satiety related feelings, indicating that
the regulation of appetite is a complex process in which different mechanism may play a role and no
one factor can be held responsible [23]. Therefore, the difference observed between women taking
the OCP and not taking the OCP warrants further investigation as these women were of a similar
body size and body composition, indicating an effect beyond that of caloric load alone. In particular,
to determine whether these results are due to a direct effect of the exogenous hormones contained
within the OCP, or to the suppression of endogenous hormonal cycling, the latter having already been
shown to influence energy and macronutrient intake [24].
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Study Limitations
As mentioned above, the caloric content and volume of the meal was fixed. Perhaps as a result of
this, some subjects anecdotally found the highest protein level difficult to eat because of strong feelings
of satiety. This problem is often addressed by the use of high protein meal replacements (e.g., “protein
shakes”); however, it remains to be investigated as to whether the metabolic response to this form of
protein intake is directly comparable to that of a mixed meal (more representative of daily-life). Given
recognition that different protein types can exert different postprandial metabolic effects [25], caution
should also be used when extrapolating the results of our study (using dairy protein) to high protein
meals in general. For example, casein and whey differ not only in amino acid composition but also in
absorption and digestion rates, with casein being a “slow” protein and whey being a “fast” protein,
all of which may be important factors for protein-stimulated metabolic effects and thermogenesis.
However, although one study has shown that whey protein stimulated thermogenesis to a greater
extent than casein and soy protein [25], other studies have been inconclusive [25].
Additionally (i) although all subjects in the present study took the combined monophasic
contraceptive pill, OCP formulations differed in terms of ethinyl estradiol concentration and progestin
type and dose, and our results do not necessarily generalize to other OCP formulations; and (ii) a priori
power calculations were only conducted for energy expenditure and not for RQ or the VAS variables,
therefore power to detect differences in these variables between groups may have been limited.
Finally, the demonstration here of differences in protein-induced thermogenesis due to OCP
represent differential responses in energy expenditure to a single meal. Whether these differences
would cumulate following multiple meals over the day so as to impact significantly on daily 24-h energy
expenditure will need to be addressed in future studies. It should be noted that even small differences
in daily energy expenditure (whether resulting from changes in BMR, in diet-induced thermogenesis
or in non-resting energy expenditure) have the potential, when cumulated over months and years,
to have an important impact on body weight regulation and in the development or prevention of
obesity [25].
5. Conclusions
With approximately three quarters of the day routinely spent in the postprandial state, differences in
diet-induced thermogenesis could have a significant impact on overall daily energy expenditure. Whilst
increasing meal protein content may present a potential means to optimise or enhance postprandial
energy expenditure, as indicated by our findings above, careful consideration needs to be paid to
factors that may influence an individual’s metabolic response to such a dietary intervention. This study
revealed a new, previously unknown finding in women taking the OCP, namely that the postprandial
thermogenic response of the test meal was inflexible to a wide range of protein content, the underlying
mechanisms of which warrant further investigations. Finally, our observed negative effect of the OCP
on dynamic protein metabolism in women adds to the list of noted, but often overlooked, side effects
of the OCP on nutritional metabolism, which includes well-known effects on vitamin (B2, B12, folate),
mineral and trace element (magnesium, zinc) metabolism. With the prevalent use of OCPs by women
of child-bearing age, such effects merit more attention within the research and clinical setting alike.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/7/1599/s1,
Figure S1: Change in resting respiratory quotient (∆RQ) following ingestion of each of three isocaloric meals
containing different protein levels (11, 23, and 31% total energy as protein). Values are mean ± SEM. OCP: oral
contraceptive pill.
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